Pembrolizumab in Asia‐Pacific patients with advanced head and neck squamous cell carcinoma: Analyses from KEYNOTE‐012

KEYNOTE‐012 was a phase Ib, multicohort study designed to investigate efficacy and safety of pembrolizumab in advanced solid tumors. Results from the subset of patients with recurrent/metastatic head and neck squamous cell carcinoma (HNSCC) from the Asia‐Pacific region are reported. Patients with re...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancer Sci
Autori principali: Tahara, Makoto, Muro, Kei, Hasegawa, Yasuhisa, Chung, Hyun Cheol, Lin, Chia‐Chi, Keam, Bhumsuk, Takahashi, Kenichi, Cheng, Jonathan D., Bang, Yung‐Jue
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2018
Soggetti:
Original Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5834807/
https://ncbi.nlm.nih.gov/pubmed/29284202
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13480
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi